Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information [1] Group 1: Investigation and Allegations - Nidec Corporation is facing scrutiny after a probe into allegations of improper accounting, which led to a significant drop in its share price [3] - Following the announcement of the investigation, Nidec's American Depositary Receipts (ADRs) fell by 22.7% on September 4, 2025, marking the largest one-day drop for the company [3] Group 2: Class Action Details - Shareholders who purchased Nidec Corporation securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]

Core Insights - Rosen Law Firm is investigating potential securities claims on behalf of Hormel Foods Corporation investors due to allegations of misleading business information [2] - Hormel Foods recently cut its earnings forecast, citing price pressures, bird flu, and a fire at its Arkansas peanut butter production facility, leading to a 9.1% drop in stock price [4] Group 1: Legal Investigation - The investigation is focused on whether Hormel Foods issued materially misleading information to the public [2] - Investors who purchased Hormel securities may be entitled to compensation through a class action without upfront costs [3] Group 2: Company Performance - Hormel Foods warned that its earnings were negatively impacted in the latest quarter due to various pressures, including price increases and operational disruptions [4] - The company announced a leadership change, parting ways with its Chief Financial Officer amid these challenges [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [2][3] Group 1: Legal Action and Stock Impact - Western Alliance Bancorporation initiated a lawsuit against Cantor Group V LLC for fraud related to collateral loans, resulting in a 10.88% stock price drop on October 16, 2025 [4] Group 2: Class Action Information - Investors who purchased Western Alliance Bancorporation securities may be entitled to compensation through a class action without any out-of-pocket fees, with Rosen Law Firm preparing to seek recovery of investor losses [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognized as a leading firm in the field, recovering hundreds of millions for investors [5]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. due to allegations of misleading statements and failure to disclose material adverse facts regarding its Long Island City property, particularly in light of disappointing financial results reported in Q3 2025 [6][7]. Group 1: Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Alexandria between January 27, 2025, and October 27, 2025, to discuss their legal rights [2]. - A federal securities class action has been filed against Alexandria, with a deadline of January 26, 2026, for investors to seek the role of lead plaintiff [3]. Group 2: Financial Performance - Alexandria reported third quarter earnings that fell short of analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [7]. - The average occupancy rate for Alexandria decreased from 94.8% in the previous year to 91.4% [7]. - Following the release of these financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [7]. Group 3: Allegations of Misconduct - The complaint alleges that Alexandria and its executives made false and misleading statements while concealing material adverse facts about the leasing value of its Long Island City property [6].

Forge Resources Reports Remaining Assays Still Pending from Phase 2 of 2025 Drill ProgramNovember 28, 2025 8:30 AM EST | Source: Forge Resources Corp.Vancouver, British Columbia--(Newsfile Corp. - November 28, 2025) - Forge Resources Corp. (CSE: FRG) (OTCQB: FRGGF) (FSE: 5YZ) ("FRG" or the "Company"), reports that remaining assay results from ALT-25-012 and 3 subsequent drill holes (ALT-25-013 to ALT-25-015) are still pending. The Company notes that heavy seasonal sample volumes have resulted ...

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, following significant stock drops attributed to alleged violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [4]. Allegations and Stock Impact - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students" to secure state funding and ignored compliance requirements, leading to poor customer experiences and higher withdrawal rates [4][5]. - Following the filing of the complaint on September 14, 2025, Stride's stock dropped by $18.60 per share, or over 11%, from $158.36 to $139.76 [5]. - On October 28, 2025, Stride acknowledged that poor customer experiences led to an estimated 10,000-15,000 fewer enrollments, resulting in a further stock drop of $83.48 per share, or more than 54%, from $153.53 to $70.05 [6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [3]. - The lawsuit is titled MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. Investor Actions - Investors are encouraged to submit their information to the law firm representing the class action, with no upfront costs for shareholders [8].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud, following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - Investors have until December 30, 2025, to request to lead the case in the U.S. District Court for the Northern District of California [3]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Company Performance - Synopsys provides design automation software, with its Design IP segment growing from 25% of revenue in 2022 to 31% in 2024 [4]. - The company reported Q3 2025 revenue for its Design IP segment at $425.9 million, a 7.7% decline year-over-year, and net income of $242.5 million, a 43% year-over-year decline [6]. Group 3: Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys stock fell nearly 36%, from $604.37 per share to $387.78 per share [6]. - The decline was attributed to customers requiring more customization for IP components, impacting the business model and economics of the Design IP segment [5][6].

INSP CLASS REMINDER: Inspire Medical Systems, Inc. Investors with Losses are Reminded to Contact BFA Law before the Imminent January 5 Securities Class Action DeadlineNovember 28, 2025 8:18 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for ...

Core Viewpoint - Jamf Holding Corp. is under investigation for potential breaches of fiduciary duties by its board of directors regarding a proposed take-private transaction at a price of $13.05 per share, which may be considered unfair to shareholders [2][4]. Group 1: Investigation Details - The investigation is led by Bleichmar Fonti & Auld LLP, focusing on whether Jamf's board and Vista Equity Partners have acted in the best interests of shareholders during the acquisition process [6][8]. - The acquisition agreement was announced on October 29, 2025, with Francisco Partners Management, L.P. offering $13.05 per share, raising concerns about the fairness of this valuation [4][5]. - Vista Equity Partners holds a significant 34.4% stake in Jamf and has the right to appoint four out of nine board members, which may create conflicts of interest in the transaction [5]. Group 2: Shareholder Actions - Current shareholders of Jamf are encouraged to seek additional information and may have legal options available to them regarding the ongoing investigation [3][7]. - BFA Law operates on a contingency fee basis, meaning shareholders will not incur costs unless the firm secures a favorable outcome [7][8].

MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors are Reminded to Contact BFA Law before the Imminent December 15 Securities Class Action DeadlineNovember 28, 2025 8:18 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of t ...